青岛海尔生物医疗股份有限公司 关于完成工商变更登记并换发营业执照的公告

Core Viewpoint - The company has approved a change in the purpose of repurchased shares, shifting from employee stock ownership plans to cancellation and reduction of registered capital [1]. Group 1: Share Repurchase and Capital Reduction - The company’s board and shareholders have agreed to adjust the use of 1,459,586 repurchased shares from "for employee stock ownership plans or equity incentives" to "for cancellation and corresponding reduction of registered capital" [1]. - The company has completed the necessary registration changes and obtained a new business license reflecting the updated registered capital of 316,492,922 yuan [1]. Group 2: Company Information - The company is named Qingdao Haier Biomedical Co., Ltd., with a unified social credit code of 91370211780374731M, established on October 28, 2005 [1]. - The company operates in various sectors including medical device technology research and development, production, sales, and after-sales services, as well as other related fields [1].